BioMarin Pharmaceutical Inc. (FRA:BM8)
Germany
· Delayed Price · Currency is EUR 45.98
-0.37 (-0.80%)
At close: Dec 5, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €8.82 billion as of December 5, 2025. Its market cap has decreased by -21.03% in one year.
Market Cap
8.82B
Enterprise Value
8.07B
Revenue
2.64B
Ranking
n/a
PE Ratio
19.88
Stock Price
€45.98
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.82B, an increase of 1,971.93%. That is a compound annual growth rate of 12.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.93B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |